Working Capital in Pharmaceuticals & Healthcare
How to interpret and apply working capital specifically when analyzing pharmaceuticals & healthcare stocks in India.
Quick Recap: What is Working Capital?
Working capital is the difference between current assets and current liabilities — measuring the short-term financial cushion available for daily operations.
Working Capital = Current Assets - Current Liabilities
How Working Capital Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical D/E (capital context)0.2-0.8x
General benchmark: Positive and stable. Negative is acceptable for companies like Amazon that collect before they pay.
Example Pharmaceuticals & Healthcare Companies to Analyze
Use the Equiscale Screener → to filter pharmaceuticals & healthcare stocks by working capital and other metrics.
Key Takeaways
- Working Capital in pharmaceuticals & healthcare should be compared against sector peers, not the market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Always cross-check with other metrics. No single ratio tells the full story.